Denali Advisors’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-27,100
| Closed | -$256K | – | 288 |
|
|
2024
Q1 | $256K | Sell |
27,100
-30,700
| -53% | -$290K | 0.08% | 204 |
|
|
2023
Q4 | $390K | Sell |
57,800
-12,800
| -18% | -$86.4K | 0.12% | 171 |
|
|
2023
Q3 | $313K | Buy |
+70,600
| New | +$313K | 0.11% | 186 |
|
|
2022
Q3 | – | Sell |
-3,900
| Closed | -$19K | – | 376 |
|
|
2022
Q2 | $19K | Hold |
3,900
| – | – | 0.01% | 308 |
|
|
2022
Q1 | $92K | Hold |
3,900
| – | – | 0.04% | 202 |
|
|
2021
Q4 | $69K | Buy |
+3,900
| New | +$69K | 0.03% | 221 |
|